Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE ROPERT : revenue, balance sheet and financial ratios

PHARMACIE ROPERT is a French company founded 2 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MONTREUIL-LE-GAST (35520), this company of category PME shows in 2025 a net income positive of 108 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE ROPERT (SIREN 982628141)
Indicator 2025
Revenue N/C
Net income 108 008 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2025, PHARMACIE ROPERT generates positive net income of 108 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

108 008 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 578%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 12%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

577.796%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

11.733%

Solvency indicators evolution
PHARMACIE ROPERT

Sector positioning

Debt ratio
577.8 2025
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Watch

In 2025, the debt ratio of PHARMACIE ROPERT (577.80) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
11.73% 2025
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Watch

In 2025, the financial autonomy of PHARMACIE ROPERT (11.7%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Positioning of PHARMACIE ROPERT in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE ROPERT is estimated at 1 715 719 € (range 1 164 295€ - 2 692 200€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1164k€ 1715k€ 2692k€
1 715 719 € Range: 1 164 295€ - 2 692 200€
NAF 5 année 2025

Valuation method used

Net Income Multiple
108 008 € × 15.9x = 1 715 720 €
Range: 1 164 296€ - 2 692 201€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE ROPERT with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE ROPERT

What is the revenue of PHARMACIE ROPERT ?

The revenue of PHARMACIE ROPERT is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE ROPERT profitable?

Yes, PHARMACIE ROPERT generated a net profit of 108 k€ in 2025.

Where is the headquarters of PHARMACIE ROPERT ?

The headquarters of PHARMACIE ROPERT is located in MONTREUIL-LE-GAST (35520), in the department Ille-et-Vilaine.

Where to find the tax return of PHARMACIE ROPERT ?

The tax return of PHARMACIE ROPERT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE ROPERT operate?

PHARMACIE ROPERT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.